Abstract:SH2B1 deficiency induces obesity and metabolic disease in mice and humans. SH2B1‐expressing neurons in the PVH and a PVHSH2B1→DRN neurocircuit are uncovered here. Activation of the PVHSH2B1→DRN neurocircuit suppresses appetite. SH2B1 directly enhances BDNF signaling in PVHSH2B1 neurons, thereby increasing the ability of the PVHSH2B1→DRN neurocircuit to defend against energy imbalance, obesity, and metabolic disease. SH2B1 mutations are associated with obesity, type 2 diabetes, and metabolic dysfunction‐associated steatotic liver disease (MASLD) in humans. Global deletion of Sh2b1 results in severe obesity, type 2 diabetes, and MASLD in mice. Neuron‐specific restoration of SH2B1 rescues the obesity phenotype of Sh2b1‐null mice, indicating that the brain is a main SH2B1 target. However, SH2B1 neurocircuits remain elusive. SH2B1‐expressing neurons in the paraventricular hypothalamus (PVHSH2B1) and a PVHSH2B1→dorsal raphe nucleus (DRN) neurocircuit are identified here. PVHSH2B1 axons monosynaptically innervate DRN neurons. Optogenetic stimulation of PVHSH2B1 axonal fibers in the DRN suppresses food intake. Chronic inhibition of PVHSH2B1 neurons causes obesity. In male and female mice, either embryonic‐onset or adult‐onset deletion of Sh2b1 in PVH neurons causes energy imbalance, obesity, insulin resistance, glucose intolerance, and MASLD. Ablation of Sh2b1 in the DRN‐projecting PVHSH2B1 subpopulation also causes energy imbalance, obesity, and metabolic disorders. Conversely, SH2B1 overexpression in either total or DRN‐projecting PVHSH2B1 neurons protects against diet‐induced obesity. SH2B1 binds to TrkB and enhances brain‐derived neurotrophic factor (BDNF) signaling. Ablation of Sh2b1 in PVHSH2B1 neurons induces BDNF resistance in the PVH, contributing to obesity. In conclusion, these results unveil a previously unrecognized PVHSH2B1→DRN neurocircuit through which SH2B1 defends against obesity by enhancing BDNF/TrkB signaling.

SH2B regulation of growth, metabolism, and longevity in both insects and mammals.

Prominin‐like, a Homolog of Mammalian CD133, Suppresses Dilp6and TOR Signaling to Maintain Body Size and Weight Indrosophila

Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice.

[Molecular Mechanism of SH2B1 in Regulating JAK2/IRS2 During Obesity Development].

Hepatic SH2B1 and SH2B2 Regulate Liver Lipid Metabolism and VLDL Secretion in Mice.

Disruption of the SH2-B Gene Causes Age-Dependent Insulin Resistance and Glucose Intolerance

SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice

Regulation of Starvation-Induced Hyperactivity by Insulin and Glucagon Signaling in Adult Drosophila

SH2B1 Defends Against Energy Imbalance, Obesity, and Metabolic Disease via a Paraventricular Hypothalamus→Dorsal Raphe Nucleus Neurocircuit

Neuronal Cbl Controls Biosynthesis of Insulin-Like Peptides in Drosophila Melanogaster

SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer’s Disease

SH2B1 in Β-Cells Regulates Glucose Metabolism by Promoting Β-Cell Survival and Islet Expansion.

NUCB1 is required for proper insulin signaling to control longevity in Drosophila

Heat shock cognate 70 genes contribute to Drosophila spermatocyte growth progression possibly through the insulin signaling pathway

Sir2 Acts through Hepatocyte Nuclear Factor 4 to maintain insulin Signaling and Metabolic Homeostasis in Drosophila

Insulin Signaling,insect Development and Ageing

Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease

New Perspective on SH2B1: an Accelerator of Cancer Progression

Par-1 Regulates Tissue Growth by Influencing Hippo Phosphorylation Status and Hippo-Salvador Association

Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling

A developmental checkpoint directs metabolic remodelling as a strategy against starvation in Drosophila